Abstract |
In the roundtable that follows, clinicians discuss a study published in this issue of the Journal in light of its methodology, relevance to practice, and implications for future research. Article discussed: Segebladh B, Borgström A, Nyberg S, et al. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder. Am J Obstet Gynecol 2009;201:139.e1-8.
|
Authors | Emily S Jungheim, Jessica J Kenerson, Nastaran Foyouzi-Yousefi, Jenifer E Allsworth, Kerri L Marquard |
Journal | American journal of obstetrics and gynecology
(Am J Obstet Gynecol)
Vol. 201
Issue 2
Pg. e1-5
(Aug 2009)
ISSN: 1097-6868 [Electronic] United States |
PMID | 19646561
(Publication Type: Comment, Journal Article)
|
Chemical References |
- Estrogens
- Gonadotropin-Releasing Hormone
- Progesterone
|
Topics |
- Drug Therapy, Combination
- Estrogens
(therapeutic use)
- Female
- Gonadotropin-Releasing Hormone
(agonists)
- Humans
- Premenstrual Syndrome
(drug therapy)
- Progesterone
(therapeutic use)
|